United States v. Steven L. Beumel

522 F. App'x 623
CourtCourt of Appeals for the Eleventh Circuit
DecidedJune 21, 2013
Docket12-15056
StatusUnpublished
Cited by1 cases

This text of 522 F. App'x 623 (United States v. Steven L. Beumel) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Steven L. Beumel, 522 F. App'x 623 (11th Cir. 2013).

Opinion

PER CURIAM:

After a guilty plea, Steven Beumel appeals his 360-month total sentence for one *625 count of recklessly tampering with a consumer product resulting in death, in violation of 18 U.S.C. § 1365(a)(2); four counts of recklessly tampering with a consumer product resulting in serious bodily injury, in violation of 18 U.S.C. § 1365(a)(3); and five counts of acquiring fentanyl, a controlled substance, by deception and subterfuge, in violation of 21 U.S.C. § 843(a)(3). After review, we affirm.

I. BACKGROUND FACTS

A. BeumePs Offense

From 2004 to 2010, Beumel worked as a licensed radiologic technician for Mayo Clinic’s Interventional Radiology Department. Beumel’s duties included, among others, preparing patients for procedures, obtaining necessary supplies, reloading syringes, ensuring sterility within the procedure rooms, and, sometimes, emptying containers with used needles and syringes. In performing his job, Beumel had access to syringes containing the narcotic fenta-nyl, a powerful, fastacting, pain reliever.

In 2006, Beumel began stealing fentanyl from the Mayo Clinic by retrieving discarded syringes containing residual fenta-nyl, replacing the syringe needles, and injecting himself with the drug. At some point, instead of (or in addition to) obtaining discarded fentanyl from the trash, Beumel began taking unused fentanyl intended for patients undergoing various medical procedures.

Specifically, if fentanyl was needed during a medical procedure, a registered nurse would take a syringe, fill it with fentanyl from a vial, mark the syringe as containing fentanyl, and place the full syringe on a cart headed to the patient. Unbeknownst to the nurse, Beumel would take the fentanyl-filled syringe, remove the safety needle, replace it with a smaller gauge needle, and inject himself with the fentanyl. Beumel would then reattach the original safety needle, fill the fentanyl-marked syringe with saline solution, and place the syringe back on the cart. The nurse would then unknowingly inject the patient with saline solution, instead of fen-tanyl, from the used syringe. The saline solution (marked as fentanyl) was injected into an access port on the intravenous (“IV”) tubing of a patient, not directly into the skin.

At the time Beumel diverted fentanyl intended for patients, he was infected with Hepatitis C (“HCV”), a transmittable virus with no known vaccine that infects the bloodstream and can damage and destroy the liver. Beumel did not know at the time that he was infected with HCV, and it is unknown exactly when or how he was infected.

Between 2007 and 2008, three Mayo Clinic patients were identified as having contracted HCV following treatment procedures at that medical facility. After an extensive investigation, healthcare investigators narrowed the cause of these infections to contamination of syringes through the diversion of fentanyl by 1 of the 21 healthcare employees assigned to the In-terventional Radiology Department at the Mayo Clinic. Twenty of those employees tested negative for HCV. After initially declining to be tested, Beumel submitted and tested positive for the same unique strand of HCV found in the three infected patients. Two more patients were subsequently identified as having been infected with the same strand of HCV. The latest infection occurred on or about November 21, 2008.

After several interviews with the healthcare investigators, Beumel admitted that he had been diverting fentanyl for personal use. Beumel further admitted that, sometime in late 2007, he heard a discussion about patients infected with HCV, and *626 from then on was “very careful” not to swap used syringes for new syringes containing fentanyl. Beumel did not think that the syringes he was using would be contaminated because they were used to inject fentanyl into the IV tubing, not directly into the patient, and because he was changing the needles.

Investigation also revealed that in 2004, before joining the Mayo Clinic and while working for another hospital, Beumel had been caught diverting fentanyl and sent to substance abuse treatment. As part of his treatment, Beumel was specifically informed about the risk of exposure to HCV from injections. Beumel’s drug abuse counseling and monitoring continued through April 2007, long past the date he began stealing fentanyl from the Mayo Clinic.

B. Beumel’s Victims

Five patients were identified who contracted HCV from Beumel’s use of the syringes. One patient experienced liver damage caused by the HCV and subsequently died from other illnesses. Another patient victim successfully eradicated his HCV by undergoing a year of aggressive and painful treatment. However, that patient victim was infected with the HCV while being treated for multiple myeloma and one week prior to receiving a high dose of chemotherapy that essentially destroyed his immune system. Though this patient was able to eradicate the HCV, having the infection while his immune system was compromised created a substantial risk of death.

Two other patient victims continued suffering from their HCV infections at the time of Beumel’s sentencing and could not undergo treatment due to their advanced age and other health problems. They both face protracted impairment of the liver as a result of the HCV.

Beumel’s fifth victim contracted HCV during a follow-up procedure for his successful liver transplant. Although his HCV was aggressively treated, the treatment negatively impacted his overall health and was discontinued without success. The HCV damaged the patient’s new liver and, after three years of fighting the disease, he died from complications related to his HCV.

C. Presentence Investigation Report

After Beumel pled guilty to each of the 10 charges in the indictment, a probation officer compiled the Presentence Investigation Report (“PSI”) and calculated Beumel’s guidelines range based on his most serious offense — product tampering resulting in death, in violation of 18 U.S.C. § 1365(a)(2) (Count 3).

The probation officer assigned Beumel a base offense level of 38, pursuant to U.S.S.G. § 2N1.1 (cross-referencing U.S.S.G. § 2A1.2, the guideline for second-degree murder) because Beumel’s offense resulted in death that did not qualify as first-degree murder. Two levels were added under U.S.S.G. § 3A1.1(b)(1) because Beumel knew or should have known that his victim was vulnerable, and another two levels under U.S.S.G. § 3B1.3 because Beumel abused his position of trust. After a two-level reduction for acceptance of responsibility, Beumel’s total offense level became 40, which, combined with a criminal history category of I, yielded a guidelines range of 292 to 365 months in prison. There was no statutory minimum sentence for any of Beumel’s offenses. The statutory maximum sentences were as follows: (1) four years for each of the five 21 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Beumel v. United States
134 S. Ct. 461 (Supreme Court, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
522 F. App'x 623, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-steven-l-beumel-ca11-2013.